Cargando…
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia
PURPOSE OF REVIEW: Cardiotoxicity by anticancer agents has emerged as a multifaceted issue and is expected to affect both mortality and morbidity. This review summarizes clinical challenges in the management of oncological patients requiring anticoagulants for atrial fibrillation (AF) also consideri...
Autores principales: | Gatti, Milo, Raschi, Emanuel, Poluzzi, Elisabetta, Martignani, Cristian, Salvagni, Stefania, Ardizzoni, Andrea, Diemberger, Igor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537958/ https://www.ncbi.nlm.nih.gov/pubmed/33025463 http://dx.doi.org/10.1007/s11897-020-00485-9 |
Ejemplares similares
-
Prevention, Detection, and Management of Heart Failure in Patients Treated for Breast Cancer
por: Broberg, Agneta Månsson, et al.
Publicado: (2020) -
Anthracycline-Related Heart Failure: Certain Knowledge and Open Questions: Where Do we Stand with Chemotherapyinduced Cardiotoxicity?
por: Robinson, Emma Louise, et al.
Publicado: (2020) -
LVEF by Multigated Acquisition Scan Compared to Other Imaging Modalities in Cardio-Oncology: a Systematic Review
por: Printezi, Markella I., et al.
Publicado: (2022) -
Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase
por: Gatti, Milo, et al.
Publicado: (2021) -
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance
por: Raschi, Emanuel, et al.
Publicado: (2020)